Literature DB >> 15659258

Hypersensitivity reactions to fluoroquinolones.

Kathrin Scherer1, Andreas J Bircher.   

Abstract

Fluoroquinolone antibiotics cause immediate and delayed hypersensitivity reactions, and may also affect internal organs and circulating blood cells. The underlying pathomechanisms are only partly understood. The extent of cross-reactivity among different quinolones depends on the type of clinical manifestation and its underlying mechanism. Despite recent advances, reliable diagnostic tests are still lacking. Recent studies have shown quinolone-specific IgE in vitro in more than 50% of patients with immediate-type reactions and a considerable cross-reactivity with related compounds. In maculopapular drug exanthems from ciprofloxacin, specific T-cell clones were identified, and cross-reactivity to related compounds was detected in approximately 50% of the clones. From re-exposure studies in patients with exanthems, cross-reactivity appears to be lower. Cellular tests such as lymphocyte transformation tests are currently not very useful. For prick and intradermal skin tests, widely divergent nonirritant test concentrations have been recommended. Desensitization may be possible in selected patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659258     DOI: 10.1007/s11882-005-0049-1

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  34 in total

1.  Trovafloxacin-induced acute hepatitis.

Authors:  M I Lucena; R J Andrade; L Rodrigo; J Salmerón; A Alvarez; M J Lopez-Garrido; R Camargo; R Alcantára
Journal:  Clin Infect Dis       Date:  2000-02       Impact factor: 9.079

2.  Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics.

Authors:  Raquel Empedrad; Amy Liebl Darter; Harry S Earl; Rebecca S Gruchalla
Journal:  J Allergy Clin Immunol       Date:  2003-09       Impact factor: 10.793

3.  Ciprofloxacin desensitization.

Authors:  J C Gea-Banacloche; D D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  1996-06       Impact factor: 10.793

4.  Cross-reactivity in murine fluoroquinolone photoallergy: exclusive usage of TCR Vbeta13 by immune T cells that recognize fluoroquinolone-photomodified cells.

Authors:  Y Tokura; N Seo; H Yagi; F Furukawa; M Takigawa
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

5.  Ciprofloxacin desensitization in a patient with cystic fibrosis.

Authors:  R R Lantner
Journal:  J Allergy Clin Immunol       Date:  1995-12       Impact factor: 10.793

Review 6.  Allergic nephropathy associated with norfloxacin and ciprofloxacin therapy. Report of two cases and review of the literature.

Authors:  H Hadimeri; G Almroth; K Cederbrant; S Eneström; P Hultman; A Lindell
Journal:  Scand J Urol Nephrol       Date:  1997-10

7.  Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus.

Authors:  M Jongen-Lavrencic; P M Schneeberger; J G van der Hoeven
Journal:  Infection       Date:  2003-12       Impact factor: 3.553

8.  A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity.

Authors:  R S Dawe; S H Ibbotson; J B Sanderson; E M Thomson; J Ferguson
Journal:  Br J Dermatol       Date:  2003-12       Impact factor: 9.302

9.  Detection of specific IgE to quinolones.

Authors:  Mariangela Manfredi; Maurizio Severino; Sergio Testi; Donatella Macchia; Giuseppe Ermini; Werner J Pichler; Paolo Campi
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

Review 10.  Quinolone photoallergy: photosensitivity dermatitis induced by systemic administration of photohaptenic drugs.

Authors:  Y Tokura
Journal:  J Dermatol Sci       Date:  1998-09       Impact factor: 4.563

View more
  11 in total

1.  Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Authors:  Eric S Orman; Hari S Conjeevaram; Raj Vuppalanchi; James W Freston; James Rochon; David E Kleiner; Paul H Hayashi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-02-26       Impact factor: 11.382

Review 2.  Update on Quinolone Allergy.

Authors:  Inmaculada Doña; Esther Moreno; Natalia Pérez-Sánchez; Inmaculada Andreu; Dolores Hernández Fernandez de Rojas; María José Torres
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

Review 3.  Road Less Traveled: Drug Hypersensitivity to Fluoroquinolones, Vancomycin, Tetracyclines, and Macrolides.

Authors:  Linda J Zhu; Anne Y Liu; Priscilla H Wong; Anna Chen Arroyo
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-29       Impact factor: 10.817

4.  Prevalence and characteristics of hospital inpatients with reported fluoroquinolone allergy.

Authors:  Geoffrey C Wall; Matthew J Taylor; Hayden L Smith
Journal:  Int J Clin Pharm       Date:  2018-03-14

5.  Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?

Authors:  Rannakoe J Lehloenya; Jonny G Peter; Ana Copascu; Jason A Trubiano; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2020-10

6.  Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy.

Authors:  Mario Sánchez-Borges; Bernard Thong; Miguel Blanca; Luis Felipe Chiaverini Ensina; Sandra González-Díaz; Paul A Greenberger; Edgardo Jares; Young-Koo Jee; Luciana Kase-Tanno; David Khan; Jung-Won Park; Werner Pichler; Antonino Romano; Maria José Torres Jaén
Journal:  World Allergy Organ J       Date:  2013-10-31       Impact factor: 4.084

Review 7.  In Vitro Diagnostic Testing for Antibiotic Allergy.

Authors:  Inmaculada Doña; Maria J Torres; Maria I Montañez; Tahia D Fernández
Journal:  Allergy Asthma Immunol Res       Date:  2017-07       Impact factor: 5.764

8.  Usefulness of In Vivo and In Vitro Diagnostic Tests in the Diagnosis of Hypersensitivity Reactions to Quinolones and in the Evaluation of Cross-Reactivity: A Comprehensive Study Including the Latest Quinolone Gemifloxacin.

Authors:  Semra Demir; Asli Gelincik; Nilgun Akdeniz; Esin Aktas-Cetin; Muge Olgac; Derya Unal; Belkis Ertek; Raif Coskun; Bahattin Colakoğlu; Gunnur Deniz; Suna Buyukozturk
Journal:  Allergy Asthma Immunol Res       Date:  2017-07       Impact factor: 5.764

9.  Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions.

Authors:  Grzegorz Porebski; Kamila Kwiecien; Magdalena Pawica; Mateusz Kwitniewski
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

10.  Hypersensitivity to fluoroquinolones: The expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone.

Authors:  Tahia D Fernández; Adriana Ariza; Francisca Palomares; María I Montañez; María Salas; Angela Martín-Serrano; Rubén Fernández; Arturo Ruiz; Miguel Blanca; Cristobalina Mayorga; María J Torres
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.